查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1765405

微流体设备系统的全球市场

Microfluidic Device Systems
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 214 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

预计到 2030 年全球微流体设备系统市场规模将达 210 亿美元

全球微流体设备系统市场规模预计在2024年为73亿美元，预计2030年将达到210亿美元，2024年至2030年的复合年增长率为19.3%。体外诊断是本报告分析的细分市场之一，预计其复合年增长率为19.3%，到分析期结束时规模将达到133亿美元。製药细分市场在分析期间内的复合年增长率预计为16.7%。

美国市场规模估计为 21 亿美元，中国市场预计复合年增长率为 18.8%

美国微流体设备系统市场规模预计2024年达到21亿美元。作为世界第二大经济体，中国预计到2030年市场规模将达到33亿美元，在2024-2030年的分析期间内，复合年增长率为18.8%。其他值得关注的区域市场包括日本和加拿大，预计在分析期间内，这两个市场的复合年增长率分别为16.9%和16.1%。在欧洲，预计德国市场的复合年增长率约为13.2%。

全球微流体设备系统市场—主要趋势与驱动因素摘要

什么是微流体装置系统？为什么它们在现代生物医学和工业应用中如此重要？

微流体装置系统是一种微型平台，可透过晶片上蚀刻的通道操控少量流体（通常在微升或纳升范围内），从而实现对化学、生物和物理过程的精确控制。这些装置整合了泵浦、阀门、感测器和搅拌机等组件，可实现诊断、药物传输、化学分析和环境监测等各种应用。微流体具有处理速度更快、试剂消费量更少、成本更低和灵敏度更高的优势，使其成为医疗保健、製药、食品安全和研究等领域的重要技术。

微流体装置系统的重要性在于其能够快速、准确且经济高效地对流体进行分析和合成，从而推动照护现场诊断、实验室晶片技术和高通量筛检的发展。透过微型化实验室流程，微流体支援个人化医疗、高效的药物研发和即时环境监测。随着工业界追求更高的精度、更高的自动化程度和更永续的製程，微流体系统已成为现代生物医学研究、临床诊断和工业应用的重要工具。

技术进步如何影响微流体设备系统市场？

技术进步显着提高了微流体装置系统的精度、多功能性和整合能力，促进了各种应用领域的创新。其中一项重要进展是使用先进材料，例如聚二甲基硅氧烷 (PDMS)、玻璃和环烯烃共聚物 (COC)，这些材料具有更高的生物相容性、耐化学性和光学透明度。这些材料增强了微流体装置的性能和可靠性，使其适用于复杂的分析、药物传输系统和即时诊断。

自动化控制系统的整合进一步增强了微流体设备的功能。自动化平台整合了感测器、致动器和软体，用于即时监测和操控流体流量、温度和压力。这种能力在数微流体等应用中至关重要，这些应用利用电讯号操控晶片上的微小液滴，从而实现快速精准的生化分析。自动化不仅提高了吞吐量和精度，还减少了人工干预，使微流体系统更具可扩展性，更能适应工业需求。

3D列印和微加工技术的进步拓展了微流体设备设计的可能性。 3D列印技术能够快速原型製作复杂微流体结构的原型，支援针对诊断、药物开发和环境测试等特定应用的客製化设备设计。软光刻和微加工技术的创新提高了微流体晶片内部组件的微型化和整合度，从而推动了将多种分析功能整合微影术单一设备中的实验室晶片设备的开发。这些创新不仅扩展了微流体系统的功能，也顺应了生物医学和工业流程微型化、自动化和精密化的大趋势。

微流体装置系统在各领域有哪些新的应用？

在对高精度、高性价比和快速分析工具的需求推动下，微流体控元件系统正在各个领域中广泛应用。在医疗保健领域，微流体广泛应用于即时诊断，能够快速检测感染疾病、癌症和心血管疾病等疾病。实验室晶片设备将样本製备、反应和检测整合在单一晶片上，用于血液检测、血糖监测和基因分析，支援个人化医疗和疾病的早期检测。微流体装置也用于器官晶片模型，该模型模拟人体器官功能，用于测试药物疗效和疾病进展，从而减少对动物模型的依赖并加速药物开发。

在製药业，微流体在药物研发中发挥着至关重要的作用。微流体能够实现候选药物的高通量筛检、奈米药物的高效合成以及药物传输系统的可控性。微流体平台使研究人员能够进行快速分析，在细胞层面上研究药物交互作用，并创建复杂的製剂，例如脂质体和奈米颗粒，并精确控制其大小和成分。这些能力能够提高药物疗效，减少副作用，并缩短开发时间，使微流体成为现代药物研究的关键。

在环境领域，微流体设备用于即时监测水质、土壤分析和污染物检测。它们能够快速现场检测重金属、病原体和农药等污染物，以支持环境保护和永续管理工作。在食品和饮料行业，微流体系统用于品管，以检测食品中的病原体、过敏原和化学污染物。能够提供快速且准确结果的微流体微流体是确保食品安全和符合监管标准的宝贵工具。微流体系统在这些领域的应用日益广泛，凸显了其在消费品和工业微流体提供准确、高效和扩充性的分析解决方案方面发挥的关键作用。

是什么推动了微流体设备系统市场的成长？

微流体设备系统市场的成长受到多种因素的推动，包括快速诊断需求的不断增长、精准医疗的进步以及药物研发和环境监测应用的日益普及。全球范围内对照护现场和分散式医疗保健解决方案的追求是主要成长要素之一。随着医疗保健提供者寻求改善可及性、降低成本并更快地获得结果，微流体系统提供了一种可扩展的解决方案，可在床边、诊所和远端位置进行检测。其体积小巧、週转速度快且样本需求量极低，使其成为快速疾病筛检和监测的理想选择。

个人化医疗日益受到重视，这进一步推动了对微流体设备系统的需求。精准医疗需要根据个人基因、环境和生活方式因素制定个人化治疗方案，而微流体设备能够有效处理基因和生物标记分析，从而支持个人化治疗方案的选择和监测。在肿瘤、感染疾病和代谢性疾病等领域，这种需求尤其强劲，因为个人化治疗方法对于患者的预后至关重要。

药物研发领域的进步也促进了微流体设备的普及。製药公司正在利用微流体平台进行高通量筛检、快速配製和候选药物测试，从而缩短开发时间并降低成本。将混合、反应和检测等多种功能整合到单一设备中，可以实现更有效率的工作流程，这使得微流体在药物研究和生物製造领域越来越具有吸引力。

日益增长的环境监测需求以及日益严格的水、土壤和食品安全法规，推动了微流体设备在污染物和病原体快速检测中的应用。其便携性、准确性和低试剂消费量使其成为已开发市场和新兴市场中即时监测的有效工具，可支援永续管理和​​合规性。

得益于材料、微型化和整合技术的持续创新，微流体设备系统市场可望实现强劲成长。这些趋势，加上对快速、准确且经济高效的分析解决方案日益增长的需求，使得微流体成为当代战略的重要组成部分，这些战略旨在改善医疗保健、加速药物开发并支持各个领域的永续实践。

部分

应用（POC测试、製药和生命科学研究、药物传输、分析设备、临床和兽医诊断、环境和工业）、工业（体外诊断、製药、医疗设备）

受访公司范例

  • Abbott Laboratories
  • Agilent Technologies, Inc.
  • Becton, Dickinson & Company
  • Bio-Rad Laboratories, Inc.
  • Cepheid, Inc.
  • Dolomite Microfluidics
  • Fluidigm Corporation
  • Johnson & Johnson
  • Micronit Microtechnologies BV
  • RainDance Technologies, Inc.
  • Roche Diagnostics（Schweiz）AG
  • Siemens Healthineers

人工智慧集成

全球产业分析师正在利用可操作的专家内容和人工智慧工具改变市场和竞争情报。

Global 特定产业SLM 的典型规范，而是建立了一个从全球专家收集的内容库，其中包括视讯录影、部落格、搜寻引擎研究以及大量的公司、产品/服务和市场数据。

关税影响係数

全球产业分析师根据公司总部所在国家、製造地、进出口状况（成品和原始OEM）预测其竞争态势的变化。这种复杂且多面向的市场动态预计将以多种方式影响竞争对手，包括销货成本成本 (COGS) 上升、盈利下降、供应链重组以及其他微观和宏观市场动态。

目录

第一章调查方法

第二章执行摘要

  • 市场概览
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 其他欧洲国家
  • 亚太地区
  • 其他地区

第四章 竞赛

简介目录
Product Code: MCP16590

Global Microfluidic Device Systems Market to Reach US$21.0 Billion by 2030

The global market for Microfluidic Device Systems estimated at US$7.3 Billion in the year 2024, is expected to reach US$21.0 Billion by 2030, growing at a CAGR of 19.3% over the analysis period 2024-2030. In-vitro diagnostics, one of the segments analyzed in the report, is expected to record a 19.3% CAGR and reach US$13.3 Billion by the end of the analysis period. Growth in the Pharmaceuticals segment is estimated at 16.7% CAGR over the analysis period.

The U.S. Market is Estimated at US$2.1 Billion While China is Forecast to Grow at 18.8% CAGR

The Microfluidic Device Systems market in the U.S. is estimated at US$2.1 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$3.3 Billion by the year 2030 trailing a CAGR of 18.8% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 16.9% and 16.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 13.2% CAGR.

Global Microfluidic Device Systems Market - Key Trends & Drivers Summarized

What Are Microfluidic Device Systems, and Why Are They So Crucial in Modern Biomedical and Industrial Applications?

Microfluidic Device Systems are miniaturized platforms that manipulate small volumes of fluids (typically in the microliter or nanoliter range) through channels etched on a chip, enabling precise control of chemical, biological, and physical processes. These devices integrate components like pumps, valves, sensors, and mixers, allowing for various applications such as diagnostics, drug delivery, chemical analysis, and environmental monitoring. Microfluidics offers advantages like faster processing, reduced reagent consumption, lower costs, and improved sensitivity, making it a key technology in sectors like healthcare, pharmaceuticals, food safety, and research.

The importance of microfluidic device systems lies in their ability to provide rapid, accurate, and cost-effective analysis and synthesis of fluids, enabling advancements in point-of-care diagnostics, lab-on-a-chip technologies, and high-throughput screening. By miniaturizing laboratory processes, microfluidics supports personalized medicine, efficient drug discovery, and real-time environmental monitoring. As industries aim for higher precision, better automation, and more sustainable processes, microfluidic systems have become essential tools in modern biomedical research, clinical diagnostics, and industrial applications.

How Are Technological Advancements Shaping the Microfluidic Device Systems Market?

Technological advancements have significantly enhanced the precision, versatility, and integration capabilities of Microfluidic Device Systems, driving innovation across diverse applications. One of the major developments is the use of advanced materials, such as PDMS (polydimethylsiloxane), glass, and cyclic olefin copolymers (COCs), which offer improved biocompatibility, chemical resistance, and optical transparency. These materials enhance the performance and reliability of microfluidic devices, making them suitable for complex assays, drug delivery systems, and real-time diagnostics.

The integration of automated control systems has further improved the functionality of microfluidic devices. Automated platforms incorporate sensors, actuators, and software that enable real-time monitoring and manipulation of fluid flow, temperature, and pressure. This capability is crucial in applications like digital microfluidics, where electrical signals are used to manipulate tiny droplets on a chip, enabling rapid and precise biochemical assays. Automation not only increases throughput and accuracy but also reduces human intervention, making microfluidic systems more scalable and adaptable to industrial needs.

Advancements in 3D printing and microfabrication techniques have expanded the design possibilities of microfluidic devices. 3D printing allows for rapid prototyping of complex microfluidic structures, supporting customized device designs for specific applications in diagnostics, drug development, and environmental testing. Innovations in microfabrication, such as soft lithography and photolithography, have improved the miniaturization and integration of components within microfluidic chips, enabling the development of lab-on-a-chip devices that combine multiple analytical functions in a single device. These technological innovations not only expand the capabilities of microfluidic systems but also align with broader trends toward miniaturization, automation, and precision in biomedical and industrial processes.

What Are the Emerging Applications of Microfluidic Device Systems Across Different Sectors?

Microfluidic Device Systems are finding expanding applications across various sectors, driven by the need for high-precision, cost-effective, and rapid analytical tools. In the healthcare sector, microfluidics is widely used in point-of-care diagnostics, enabling rapid tests for conditions like infectious diseases, cancer, and cardiovascular disorders. Lab-on-a-chip devices, which integrate sample preparation, reaction, and detection on a single chip, are used for blood testing, glucose monitoring, and genetic analysis, supporting personalized medicine and early disease detection. Microfluidic devices are also used in organ-on-a-chip models, which simulate human organ functions to test drug effects and disease progression, reducing the reliance on animal models and accelerating drug development.

In the pharmaceutical industry, microfluidics plays a critical role in drug discovery and development. It enables high-throughput screening of drug candidates, efficient synthesis of nanomedicines, and controlled drug delivery systems. Microfluidic platforms allow researchers to perform rapid assays, study drug interactions at the cellular level, and create complex formulations like liposomes and nanoparticles with precise control over size and composition. These capabilities enhance drug efficacy, reduce side effects, and shorten development timelines, making microfluidics indispensable in modern drug research.

In the environmental sector, microfluidic devices are used for real-time monitoring of water quality, soil analysis, and detection of pollutants. They enable rapid, on-site testing for contaminants like heavy metals, pathogens, and pesticides, supporting efforts in environmental protection and sustainable management. In the food and beverage industry, microfluidic systems are employed for quality control, detecting pathogens, allergens, and chemical contaminants in food products. Their ability to provide quick and accurate results makes them valuable tools for ensuring food safety and compliance with regulatory standards. The expanding applications of microfluidic device systems across these sectors highlight their critical role in enabling precise, efficient, and scalable analytical solutions in both consumer and industrial settings.

What Drives Growth in the Microfluidic Device Systems Market?

The growth in the Microfluidic Device Systems market is driven by several factors, including increasing demand for rapid diagnostics, advancements in precision medicine, and rising adoption in drug discovery and environmental monitoring. One of the primary growth drivers is the global push for point-of-care diagnostics and decentralized healthcare solutions. As healthcare providers aim to improve access, reduce costs, and deliver faster results, microfluidic systems offer a scalable solution for performing tests at the bedside, in clinics, or in remote locations. Their small size, rapid turnaround, and minimal sample requirements make them ideal for quick disease screening and monitoring.

The growing emphasis on personalized medicine has further fueled demand for microfluidic device systems. As precision medicine requires tailored treatment plans based on individual genetic, environmental, and lifestyle factors, microfluidic devices enable efficient processing of genetic and biomarker analyses, supporting personalized therapy selection and monitoring. This demand is particularly strong in fields like oncology, infectious diseases, and metabolic disorders, where individualized treatment approaches are critical for patient outcomes.

Advancements in drug discovery and development have also contributed to the adoption of microfluidic devices. Pharmaceutical companies use microfluidic platforms for high-throughput screening, rapid formulation, and testing of drug candidates, reducing development time and costs. The ability to integrate multiple functions, such as mixing, reaction, and detection, in a single device supports more efficient workflows, increasing the appeal of microfluidics in drug research and biomanufacturing.

Rising environmental monitoring needs and stricter regulations for water, soil, and food safety have driven the use of microfluidic devices for rapid detection of contaminants and pathogens. Their portability, accuracy, and low reagent consumption make them effective tools for real-time monitoring in both developed and emerging markets, supporting sustainable management and regulatory compliance.

With ongoing innovations in materials, miniaturization, and integration technologies, the microfluidic device systems market is poised for robust growth. These trends, combined with increasing demand for rapid, accurate, and cost-effective analytical solutions, make microfluidics a vital component of modern strategies focused on improving healthcare, accelerating drug development, and supporting sustainable practices across various sectors.

SCOPE OF STUDY:

The report analyzes the Microfluidic Device Systems market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Application (Point of Care Testing, Pharmaceutical and Life Science Research, Drug Delivery, Analytical Devices, Clinical and Veterinary Diagnostics, Environment and Industrial); Industry (In-vitro Diagnostics, Pharmaceuticals, Medical Devices)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 23 Featured) -

  • Abbott Laboratories
  • Agilent Technologies, Inc.
  • Becton, Dickinson & Company
  • Bio-Rad Laboratories, Inc.
  • Cepheid, Inc.
  • Dolomite Microfluidics
  • Fluidigm Corporation
  • Johnson & Johnson
  • Micronit Microtechnologies B.V.
  • RainDance Technologies, Inc.
  • Roche Diagnostics (Schweiz) AG
  • Siemens Healthineers

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Microfluidic Device Systems - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Growing Demand for Point-of-Care Diagnostics Drives Microfluidic Device Adoption
    • Advancements in Lab-on-a-Chip Technology Propel Market Growth
    • Increasing Use in Drug Discovery Expands Microfluidics Market Opportunities
    • Miniaturization of Medical Devices Strengthens Business Case for Microfluidics
    • Expanding Use in Genomics and Proteomics Sets the Stage for Growth
    • Strong Demand for Rapid Testing During Disease Outbreaks Generates Demand
    • Use in Cell Analysis and Manipulation Expands Addressable Market
    • Growing Focus on Organ-on-Chip Technology Drives Microfluidics Adoption
    • Expanding Applications in Food Safety Testing Spur Microfluidic Adoption
    • Growing Use in Environmental Monitoring Generates Demand for Devices
    • Rising Focus on Microfluidics in Biopharmaceutical Production Sustains Growth
    • Increasing Demand for Home Healthcare Devices Sets the Stage for Microfluidics Expansion
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Microfluidic Device Systems Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Microfluidic Device Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Microfluidic Device Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Microfluidic Device Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for In-vitro diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for In-vitro diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for In-vitro diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Pharmaceuticals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Pharmaceuticals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Pharmaceuticals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Medical Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Medical Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Medical Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Point of care testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Point of care testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Point of care testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Pharmaceutical and life science research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Pharmaceutical and life science research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Pharmaceutical and life science research by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Drug delivery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Drug delivery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Drug delivery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Analytical devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Analytical devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Analytical devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Clinical and veterinary diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Clinical and veterinary diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Clinical and veterinary diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Environment and Industrial by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Environment and Industrial by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for Environment and Industrial by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Microfluidic Device Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 32: USA Recent Past, Current & Future Analysis for Microfluidic Device Systems by Industry - In-vitro diagnostics, Pharmaceuticals and Medical Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Microfluidic Device Systems by Industry - In-vitro diagnostics, Pharmaceuticals and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: USA 15-Year Perspective for Microfluidic Device Systems by Industry - Percentage Breakdown of Value Sales for In-vitro diagnostics, Pharmaceuticals and Medical Devices for the Years 2015, 2025 & 2030
    • TABLE 35: USA Recent Past, Current & Future Analysis for Microfluidic Device Systems by Application - Point of care testing, Pharmaceutical and life science research, Drug delivery, Analytical devices, Clinical and veterinary diagnostics and Environment and Industrial - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Microfluidic Device Systems by Application - Point of care testing, Pharmaceutical and life science research, Drug delivery, Analytical devices, Clinical and veterinary diagnostics and Environment and Industrial Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: USA 15-Year Perspective for Microfluidic Device Systems by Application - Percentage Breakdown of Value Sales for Point of care testing, Pharmaceutical and life science research, Drug delivery, Analytical devices, Clinical and veterinary diagnostics and Environment and Industrial for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Microfluidic Device Systems by Industry - In-vitro diagnostics, Pharmaceuticals and Medical Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Canada Historic Review for Microfluidic Device Systems by Industry - In-vitro diagnostics, Pharmaceuticals and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: Canada 15-Year Perspective for Microfluidic Device Systems by Industry - Percentage Breakdown of Value Sales for In-vitro diagnostics, Pharmaceuticals and Medical Devices for the Years 2015, 2025 & 2030
    • TABLE 41: Canada Recent Past, Current & Future Analysis for Microfluidic Device Systems by Application - Point of care testing, Pharmaceutical and life science research, Drug delivery, Analytical devices, Clinical and veterinary diagnostics and Environment and Industrial - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Canada Historic Review for Microfluidic Device Systems by Application - Point of care testing, Pharmaceutical and life science research, Drug delivery, Analytical devices, Clinical and veterinary diagnostics and Environment and Industrial Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: Canada 15-Year Perspective for Microfluidic Device Systems by Application - Percentage Breakdown of Value Sales for Point of care testing, Pharmaceutical and life science research, Drug delivery, Analytical devices, Clinical and veterinary diagnostics and Environment and Industrial for the Years 2015, 2025 & 2030
  • JAPAN
    • Microfluidic Device Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 44: Japan Recent Past, Current & Future Analysis for Microfluidic Device Systems by Industry - In-vitro diagnostics, Pharmaceuticals and Medical Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Japan Historic Review for Microfluidic Device Systems by Industry - In-vitro diagnostics, Pharmaceuticals and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: Japan 15-Year Perspective for Microfluidic Device Systems by Industry - Percentage Breakdown of Value Sales for In-vitro diagnostics, Pharmaceuticals and Medical Devices for the Years 2015, 2025 & 2030
    • TABLE 47: Japan Recent Past, Current & Future Analysis for Microfluidic Device Systems by Application - Point of care testing, Pharmaceutical and life science research, Drug delivery, Analytical devices, Clinical and veterinary diagnostics and Environment and Industrial - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Japan Historic Review for Microfluidic Device Systems by Application - Point of care testing, Pharmaceutical and life science research, Drug delivery, Analytical devices, Clinical and veterinary diagnostics and Environment and Industrial Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: Japan 15-Year Perspective for Microfluidic Device Systems by Application - Percentage Breakdown of Value Sales for Point of care testing, Pharmaceutical and life science research, Drug delivery, Analytical devices, Clinical and veterinary diagnostics and Environment and Industrial for the Years 2015, 2025 & 2030
  • CHINA
    • Microfluidic Device Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 50: China Recent Past, Current & Future Analysis for Microfluidic Device Systems by Industry - In-vitro diagnostics, Pharmaceuticals and Medical Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: China Historic Review for Microfluidic Device Systems by Industry - In-vitro diagnostics, Pharmaceuticals and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: China 15-Year Perspective for Microfluidic Device Systems by Industry - Percentage Breakdown of Value Sales for In-vitro diagnostics, Pharmaceuticals and Medical Devices for the Years 2015, 2025 & 2030
    • TABLE 53: China Recent Past, Current & Future Analysis for Microfluidic Device Systems by Application - Point of care testing, Pharmaceutical and life science research, Drug delivery, Analytical devices, Clinical and veterinary diagnostics and Environment and Industrial - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: China Historic Review for Microfluidic Device Systems by Application - Point of care testing, Pharmaceutical and life science research, Drug delivery, Analytical devices, Clinical and veterinary diagnostics and Environment and Industrial Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: China 15-Year Perspective for Microfluidic Device Systems by Application - Percentage Breakdown of Value Sales for Point of care testing, Pharmaceutical and life science research, Drug delivery, Analytical devices, Clinical and veterinary diagnostics and Environment and Industrial for the Years 2015, 2025 & 2030
  • EUROPE
    • Microfluidic Device Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Microfluidic Device Systems by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for Microfluidic Device Systems by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: Europe 15-Year Perspective for Microfluidic Device Systems by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 59: Europe Recent Past, Current & Future Analysis for Microfluidic Device Systems by Industry - In-vitro diagnostics, Pharmaceuticals and Medical Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Europe Historic Review for Microfluidic Device Systems by Industry - In-vitro diagnostics, Pharmaceuticals and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: Europe 15-Year Perspective for Microfluidic Device Systems by Industry - Percentage Breakdown of Value Sales for In-vitro diagnostics, Pharmaceuticals and Medical Devices for the Years 2015, 2025 & 2030
    • TABLE 62: Europe Recent Past, Current & Future Analysis for Microfluidic Device Systems by Application - Point of care testing, Pharmaceutical and life science research, Drug delivery, Analytical devices, Clinical and veterinary diagnostics and Environment and Industrial - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Europe Historic Review for Microfluidic Device Systems by Application - Point of care testing, Pharmaceutical and life science research, Drug delivery, Analytical devices, Clinical and veterinary diagnostics and Environment and Industrial Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: Europe 15-Year Perspective for Microfluidic Device Systems by Application - Percentage Breakdown of Value Sales for Point of care testing, Pharmaceutical and life science research, Drug delivery, Analytical devices, Clinical and veterinary diagnostics and Environment and Industrial for the Years 2015, 2025 & 2030
  • FRANCE
    • Microfluidic Device Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 65: France Recent Past, Current & Future Analysis for Microfluidic Device Systems by Industry - In-vitro diagnostics, Pharmaceuticals and Medical Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: France Historic Review for Microfluidic Device Systems by Industry - In-vitro diagnostics, Pharmaceuticals and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: France 15-Year Perspective for Microfluidic Device Systems by Industry - Percentage Breakdown of Value Sales for In-vitro diagnostics, Pharmaceuticals and Medical Devices for the Years 2015, 2025 & 2030
    • TABLE 68: France Recent Past, Current & Future Analysis for Microfluidic Device Systems by Application - Point of care testing, Pharmaceutical and life science research, Drug delivery, Analytical devices, Clinical and veterinary diagnostics and Environment and Industrial - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: France Historic Review for Microfluidic Device Systems by Application - Point of care testing, Pharmaceutical and life science research, Drug delivery, Analytical devices, Clinical and veterinary diagnostics and Environment and Industrial Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: France 15-Year Perspective for Microfluidic Device Systems by Application - Percentage Breakdown of Value Sales for Point of care testing, Pharmaceutical and life science research, Drug delivery, Analytical devices, Clinical and veterinary diagnostics and Environment and Industrial for the Years 2015, 2025 & 2030
  • GERMANY
    • Microfluidic Device Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 71: Germany Recent Past, Current & Future Analysis for Microfluidic Device Systems by Industry - In-vitro diagnostics, Pharmaceuticals and Medical Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Germany Historic Review for Microfluidic Device Systems by Industry - In-vitro diagnostics, Pharmaceuticals and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: Germany 15-Year Perspective for Microfluidic Device Systems by Industry - Percentage Breakdown of Value Sales for In-vitro diagnostics, Pharmaceuticals and Medical Devices for the Years 2015, 2025 & 2030
    • TABLE 74: Germany Recent Past, Current & Future Analysis for Microfluidic Device Systems by Application - Point of care testing, Pharmaceutical and life science research, Drug delivery, Analytical devices, Clinical and veterinary diagnostics and Environment and Industrial - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Germany Historic Review for Microfluidic Device Systems by Application - Point of care testing, Pharmaceutical and life science research, Drug delivery, Analytical devices, Clinical and veterinary diagnostics and Environment and Industrial Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: Germany 15-Year Perspective for Microfluidic Device Systems by Application - Percentage Breakdown of Value Sales for Point of care testing, Pharmaceutical and life science research, Drug delivery, Analytical devices, Clinical and veterinary diagnostics and Environment and Industrial for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 77: Italy Recent Past, Current & Future Analysis for Microfluidic Device Systems by Industry - In-vitro diagnostics, Pharmaceuticals and Medical Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Italy Historic Review for Microfluidic Device Systems by Industry - In-vitro diagnostics, Pharmaceuticals and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: Italy 15-Year Perspective for Microfluidic Device Systems by Industry - Percentage Breakdown of Value Sales for In-vitro diagnostics, Pharmaceuticals and Medical Devices for the Years 2015, 2025 & 2030
    • TABLE 80: Italy Recent Past, Current & Future Analysis for Microfluidic Device Systems by Application - Point of care testing, Pharmaceutical and life science research, Drug delivery, Analytical devices, Clinical and veterinary diagnostics and Environment and Industrial - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Italy Historic Review for Microfluidic Device Systems by Application - Point of care testing, Pharmaceutical and life science research, Drug delivery, Analytical devices, Clinical and veterinary diagnostics and Environment and Industrial Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: Italy 15-Year Perspective for Microfluidic Device Systems by Application - Percentage Breakdown of Value Sales for Point of care testing, Pharmaceutical and life science research, Drug delivery, Analytical devices, Clinical and veterinary diagnostics and Environment and Industrial for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Microfluidic Device Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 83: UK Recent Past, Current & Future Analysis for Microfluidic Device Systems by Industry - In-vitro diagnostics, Pharmaceuticals and Medical Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: UK Historic Review for Microfluidic Device Systems by Industry - In-vitro diagnostics, Pharmaceuticals and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: UK 15-Year Perspective for Microfluidic Device Systems by Industry - Percentage Breakdown of Value Sales for In-vitro diagnostics, Pharmaceuticals and Medical Devices for the Years 2015, 2025 & 2030
    • TABLE 86: UK Recent Past, Current & Future Analysis for Microfluidic Device Systems by Application - Point of care testing, Pharmaceutical and life science research, Drug delivery, Analytical devices, Clinical and veterinary diagnostics and Environment and Industrial - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: UK Historic Review for Microfluidic Device Systems by Application - Point of care testing, Pharmaceutical and life science research, Drug delivery, Analytical devices, Clinical and veterinary diagnostics and Environment and Industrial Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: UK 15-Year Perspective for Microfluidic Device Systems by Application - Percentage Breakdown of Value Sales for Point of care testing, Pharmaceutical and life science research, Drug delivery, Analytical devices, Clinical and veterinary diagnostics and Environment and Industrial for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 89: Rest of Europe Recent Past, Current & Future Analysis for Microfluidic Device Systems by Industry - In-vitro diagnostics, Pharmaceuticals and Medical Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Rest of Europe Historic Review for Microfluidic Device Systems by Industry - In-vitro diagnostics, Pharmaceuticals and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: Rest of Europe 15-Year Perspective for Microfluidic Device Systems by Industry - Percentage Breakdown of Value Sales for In-vitro diagnostics, Pharmaceuticals and Medical Devices for the Years 2015, 2025 & 2030
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Microfluidic Device Systems by Application - Point of care testing, Pharmaceutical and life science research, Drug delivery, Analytical devices, Clinical and veterinary diagnostics and Environment and Industrial - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Rest of Europe Historic Review for Microfluidic Device Systems by Application - Point of care testing, Pharmaceutical and life science research, Drug delivery, Analytical devices, Clinical and veterinary diagnostics and Environment and Industrial Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: Rest of Europe 15-Year Perspective for Microfluidic Device Systems by Application - Percentage Breakdown of Value Sales for Point of care testing, Pharmaceutical and life science research, Drug delivery, Analytical devices, Clinical and veterinary diagnostics and Environment and Industrial for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Microfluidic Device Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 95: Asia-Pacific Recent Past, Current & Future Analysis for Microfluidic Device Systems by Industry - In-vitro diagnostics, Pharmaceuticals and Medical Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Asia-Pacific Historic Review for Microfluidic Device Systems by Industry - In-vitro diagnostics, Pharmaceuticals and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: Asia-Pacific 15-Year Perspective for Microfluidic Device Systems by Industry - Percentage Breakdown of Value Sales for In-vitro diagnostics, Pharmaceuticals and Medical Devices for the Years 2015, 2025 & 2030
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Microfluidic Device Systems by Application - Point of care testing, Pharmaceutical and life science research, Drug delivery, Analytical devices, Clinical and veterinary diagnostics and Environment and Industrial - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for Microfluidic Device Systems by Application - Point of care testing, Pharmaceutical and life science research, Drug delivery, Analytical devices, Clinical and veterinary diagnostics and Environment and Industrial Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: Asia-Pacific 15-Year Perspective for Microfluidic Device Systems by Application - Percentage Breakdown of Value Sales for Point of care testing, Pharmaceutical and life science research, Drug delivery, Analytical devices, Clinical and veterinary diagnostics and Environment and Industrial for the Years 2015, 2025 & 2030
  • REST OF WORLD
    • TABLE 101: Rest of World Recent Past, Current & Future Analysis for Microfluidic Device Systems by Industry - In-vitro diagnostics, Pharmaceuticals and Medical Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Rest of World Historic Review for Microfluidic Device Systems by Industry - In-vitro diagnostics, Pharmaceuticals and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: Rest of World 15-Year Perspective for Microfluidic Device Systems by Industry - Percentage Breakdown of Value Sales for In-vitro diagnostics, Pharmaceuticals and Medical Devices for the Years 2015, 2025 & 2030
    • TABLE 104: Rest of World Recent Past, Current & Future Analysis for Microfluidic Device Systems by Application - Point of care testing, Pharmaceutical and life science research, Drug delivery, Analytical devices, Clinical and veterinary diagnostics and Environment and Industrial - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Rest of World Historic Review for Microfluidic Device Systems by Application - Point of care testing, Pharmaceutical and life science research, Drug delivery, Analytical devices, Clinical and veterinary diagnostics and Environment and Industrial Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: Rest of World 15-Year Perspective for Microfluidic Device Systems by Application - Percentage Breakdown of Value Sales for Point of care testing, Pharmaceutical and life science research, Drug delivery, Analytical devices, Clinical and veterinary diagnostics and Environment and Industrial for the Years 2015, 2025 & 2030

IV. COMPETITION